1. Efficacy of a Biorevitalizing-Filler Solution on All Skin Aspects: 10 Years Approach through in Vitro Studies and Clinical Trials
- Author
-
Robin, Sophie, Fanian, Férial, Courderot-Masuyer, Carol, Tordjman, Michel, Braccini, Frederic, Boisnic, Sylvie, Philippon, Valérie, Vincent, Anne Grand, Salomon, Catherine, Manfait, Michel, Humbert, Philippe, Piccerelle, Philippe, Bioexigence SAS, Besançon, France, Laboratoires Fill-Med, Paris, France, Aesthetic Doctor, Paris, France, Aesthetic Surgeon, Nice, France, Gredeco SARL, Paris, France, Laboratoires Multaler, Argenteuil, France, Reims University, Pharmaceutical Faculty, Reims, France, Université Bourgogne Franche-Comté [COMUE] (UBFC), Institut méditerranéen de biodiversité et d'écologie marine et continentale (IMBE), Avignon Université (AU)-Aix Marseille Université (AMU)-Institut de recherche pour le développement [IRD] : UMR237-Centre National de la Recherche Scientifique (CNRS), and University of Bourgogne-Franche Comté, Besançon, France
- Subjects
Skin Biorevitalization ,Skin Booster ,Mesotherapy ,[SDV]Life Sciences [q-bio] ,Skin Rejuvenation ,Hyaluronic Acid ,NCTF 135HA - Abstract
International audience; Introduction: Skin aging is the result of many cellular dysfunctions over time particularly the fibroblasts and the keratinocytes. These dysfunctions could be decelerated by the preventive effects of some skin treatments such as Intradermal injections. NCTF 135HA has a polycomponent formulation designed to improve the efficacy of non-cross linked hyaluronic acid (as a micro-filler) on fibroblasts function. Although NCTF 135HA has been used by aesthetic practitioners since 20 years, we have analyzed all in vitro, ex vivo and in vivo studies during past 10 years in order to summarized its anti-aging
- Published
- 2021